Platt HL, Cardona JF, Haranaka M, Schwartz HI, et al. A phase 3 trial of safety, tolerability, and immunogenicity of V114, 15-valent pneumococcal conjugate vaccine, compared with 13-valent pneumococcal conjugate vaccine in adults 50 years of age and older (PNEU-AGE). Vaccine 2021 Sep 7. pii: S0264-410X(21)01097.
PMID: 34507861